Onvansertib (NMS-P937)
Product Specifications
CAS Number
1034616-18-6
Synonyms
PCM-075, NMS1286937
Target
PLK
Applications
Cell Cycle
Smiles
CN1CCN (CC1) C2=CC (=C (C=C2) OC (F) (F) F) NC3=NC=C4CCC5=C (C4=N3) N (N=C5C (=O) N) CCO
Molecular Formula
C24H27F3N8O3
Additionnal Information
Onvansertib (NMS-P937, PCM-075, NMS1286937) is an orally available, selective Polo-like Kinase 1 (PLK1) inhibitor with IC50 of 2 nM, 5000-fold selectivity over PLK2/PLK3. Onvansertib (NMS-P937) potently causes a mitotic cell-cycle arrest followed by apoptosis in cancer cell lines and inhibits tumor growth. Phase 1.
Storage Conditions
2 years -80 in solvent
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15186641 1 Vial
Lentiviral mouse Cdc25b shRNA (UAS) - Lentiviral mouse Cdc25b shRNA (UAS) (25)
Sign In for Pricing
View Details 
LV709797 1.0 µg DNA
ERCC1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV)
Sign In for Pricing
View Details 
OR1102514-01 100 mg
1- (6- (Diethylamino) pyrimidin-4-yl) piperidine-4-carboxylic acid
Sign In for Pricing
View Details OR1102514-02 250 mg
1- (6- (Diethylamino) pyrimidin-4-yl) piperidine-4-carboxylic acid
Sign In for Pricing
View Details